Get the Stockscreener App
3.26
2.69%
-0.09
After Hours:
3.26
Cibus Inc stock is traded at $3.26, with a volume of 252.84K.
It is down -2.69% in the last 24 hours and down -51.85% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$3.35
Open:
$3.35
24h Volume:
252.84K
Relative Volume:
1.15
Market Cap:
$83.22M
Revenue:
$1.82M
Net Income/Loss:
$-267.63M
P/E Ratio:
-0.1811
EPS:
-18
Net Cash Flow:
$-50.53M
1W Performance:
-8.30%
1M Performance:
-51.85%
6M Performance:
-85.49%
1Y Performance:
-82.11%
1-Day Range:
$3.09
$3.4188
1-Week Range:
$3.09
$3.9092
52-Week Range:
$3.09
$23.18
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Cibus Inc Stock (CBUS) Latest News
Cibus, Inc. (NASDAQ:CBUS) Short Interest Update - MarketBeat
Cibus, Inc. (NASDAQ:CBUS) Short Interest Update - Defense World
Rhumbline Advisers Takes Position in Cibus, Inc. (NASDAQ:CBUS) - Defense World
516,000 Shares in Cibus, Inc. (NASDAQ:CBUS) Purchased by Armistice Capital LLC - MarketBeat
Cibus stock plunges to 52-week low of $3.54 amid market challenges - Investing.com Australia
Cibus stock plunges to 52-week low of $3.54 amid market challenges - Investing.com India
Cibus stock plunges to 52-week low of $3.54 amid market challenges - Investing.com
Cibus stock plunges to 52-week low of $3.54 amid market challenges - Investing.com UK
53,662 Shares in Cibus, Inc. (NASDAQ:CBUS) Purchased by Bank of New York Mellon Corp - Defense World
Unveiling 5 Analyst Insights On Cibus - Benzinga
Cibus (NASDAQ:CBUS) Price Target Cut to $23.50 by Analysts at Alliance Global Partners - Defense World
Cibus (NASDAQ:CBUS) PT Lowered to $23.50 at Alliance Global Partners - MarketBeat
Cibus to Participate in the Food+ Forum during the 79th Session of the United Nations General Assembly - StockTitan
Cibus announces partial exercise of underwriters' option - Investing.com
Cibus (NASDAQ:CBUS) Price Target Lowered to $20.00 at Canaccord Genuity Group - Defense World
Expert Ratings For Cibus - Benzinga
Cibus (NASDAQ:CBUS) Given New $20.00 Price Target at Canaccord Genuity Group - MarketBeat
Cibus price target lowered to $20 from $21 at Canaccord - TipRanks
In the Green: Cibus Inc (CBUS) Closes at 3.60, Up/Down -28.95 from Previous Day - The Dwinnex
Cibus sets price for 3 million share public offering By Investing.com - Investing.com Canada
Cibus shares price target cut to $20 by Canaccord Genuity - Investing.com
Cibus announces public offering of Class A stock By Investing.com - Investing.com Australia
Cibus announces strategic realignment and trait development updates By Investing.com - Investing.com Australia
Company’s Banking Stock: Dissecting a -60.21% Quarterly Revenue Decline Amid Growth - The InvestChronicle
Dow Jumps Over 100 Points; Fed Cuts Interest Rates By 0.5% - Benzinga
Cibus Global stock hits 52-week low at $4 amid market challenges - Investing.com
Why Cibus (CBUS) Stock Is Down 21% Wednesday - Benzinga
Cibus Shares Fall on Plan to Raise $12 Million in Offering - MarketWatch
Cibus 3M share Spot Secondary priced at $4.00 - TipRanks
Cibus sets price for 3 million share public offering - Investing.com
Cibus Announces Pricing of Public Offering of Class A Common Stock - ForexTV.com
Cibus Announces Pricing of Public Offering of Class A Common Stock - Leader-Telegram
Cibus Announces Pricing of Public Offering of Class A Common Stock - StockTitan
Cibus announces public offering of Class A stock By Investing.com - Investing.com Canada
Cibus announces public offering of Class A stock - Investing.com India
Cibus announces strategic realignment and trait development updates - Investing.com India
Cibus announces strategic realignment and trait development updates - Investing.com
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock - ForexTV.com
Cibus announces public offering of Class A stock - Investing.com
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock - StockTitan
Market Boosts Cibus (CBUS) Stock After Key Field Trials - Stocks Telegraph
Cibus completes first field trials in UK for pod shatter reduction - TipRanks
Cibus Completes First Field Trials in UK for Pod Shatter Reduction in Winter Oilseed Rape - ForexTV.com
Cibus Completes First Field Trials in UK for Pod Shatter Reduction in Winter Oilseed Rape - StockTitan
Global Genetic Engineering Market Size To Worth USD 8.95 Billion By 2033 | CAGR Of 20.82% - GlobeNewswire Inc.
CRISPR and Cas Gene Market Key Companies | AstraZeneca plc., Addgene, Beam Therapeutics, Cibus - Cauverynews
FineMark National Bank & Trust Has $202,000 Stock Position in Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus stock plunges to 52-week low, hits $5.05 amid market challenges - Investing.com Canada
Cibus stock plunges to 52-week low, hits $5.05 amid market challenges - Investing.com
Cibus (NASDAQ:CBUS) Trading Down 9.5% - Defense World
Cibus (NASDAQ:CBUS) Trading Down 9.5% - MarketBeat
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):